Skip to content
Friends of Cancer Research FOCR 30 Year Anniversary FOCR 30 Year Anniversary
  • About
    • About Friends
    • Team
    • Board of Directors
    • Financials & Policies
    • Scientific Reports
    • 30th Anniversary
  • Projects
    • View All Projects
    • Research Partnerships
      • ai.RECIST Project
      • ctMoniTR Project
      • Digital PATH Project
      • ECA Pilot
    • Policy Initiatives
      • Cell & Gene Therapies
      • Clinical Trial Eligibility Criteria
      • Interim OS Project
      • Lung-MAP
      • Tolerability & Dosing
    • Analyses
      • Drug Development Dashboards
      • About Breakthrough Therapies
      • Search Breakthrough Therapies
  • Policy Portfolio
  • Events
    • Upcoming Events
    • Past Events
    • Annual Meeting
    • Cancer Leadership Awards
  • News
    • In The News
    • Blog: Engaging Innovation
    • Press Releases
  • Publications
    • View All Publications
    • Peer Reviewed Publications
    • Scientific Reports
    • White Papers
    • Posters
  • Advocacy
    • Friends Advocacy Initiatives
    • Advisory Advocates
    • Advocacy Newsletter
    • Advocacy Education Programs
    • ProgressforPatients.org
    • Progreso para Pacientes
  • Donate
Search
  • About
    • About Friends
    • Team
    • Board of Directors
    • Financials & Policies
    • Scientific Reports
    • 30th Anniversary
  • Projects
    • View All Projects
    • Research Partnerships
      • ai.RECIST Project
      • ctMoniTR Project
      • Digital PATH Project
      • ECA Pilot
    • Policy Initiatives
      • Cell & Gene Therapies
      • Clinical Trial Eligibility Criteria
      • Interim OS Project
      • Lung-MAP
      • Tolerability & Dosing
    • Analyses
      • Drug Development Dashboards
      • About Breakthrough Therapies
      • Search Breakthrough Therapies
  • Policy Portfolio
  • Events
    • Upcoming Events
    • Past Events
    • Annual Meeting
    • Cancer Leadership Awards
  • News
    • In The News
    • Blog: Engaging Innovation
    • Press Releases
  • Publications
    • View All Publications
    • Peer Reviewed Publications
    • Scientific Reports
    • White Papers
    • Posters
  • Advocacy
    • Friends Advocacy Initiatives
    • Advisory Advocates
    • Advocacy Newsletter
    • Advocacy Education Programs
    • ProgressforPatients.org
    • Progreso para Pacientes
  • Donate
  • twitter
  • linkedin
  • youtube
Close

Impact Reports

 With Your Partnership, We Continue to Drive Progress

We advocate for smarter science and regulations to cultivate progress and discover new paths for innovation to succeed. We are proud to work alongside leaders in our field to advance cancer research and treatment.

Below are all Friends of Cancer Research Impact Reports, detailing our impact each year to drive innovation through research and policy solutions for patients.

2024 Impact Report: Powering Advances

View Report »

2023 Impact Report: Evolving Innovation

View Report »

2022 Impact Report: Patient-Centered Innovation

View Report »

25th Anniversary Impact Report

View Report »

2020 Impact Report: Advancing Innovation for Patients

View Report »

2019 Impact Report

View Report »

2018 Annual Report

View Report »

2017 Annual Report

View Report »

2016 Annual Report

View Report »

2015 Annual Report

View Report »

2014 Annual Report

View Report »

2013 Annual Report

View Report »

2012 Annual Report

View Report »

2011 Annual Report

View Report »

2010 Annual Report

View Report »

2009 Annual Report

View Report »

2008 Annual Report

View Report »

2007 Annual Report

View Report »
Friends of Cancer Research

1800 M Street NW, Suite 1050 South,
Washington, DC 20036
Phone: (202) 944-6700

Friends of Cancer Research is a 501 (C)(3) non-profit organization.
Our tax ID number is 52-1983273.

  • About
  • Careers
  • Contact
  • Donate
  • Glossary of Terms
  • Privacy Policy
  • Policy on Corporate Partnerships
  • Terms & Conditions
  • Media Resources

© Copyright 2026 Friends of Cancer Research. All rights reserved.   Legal

  • twitter
  • linkedin
  • youtube